Nu Skin Enterprises, Inc.

NUS ·Healthcare, Medical Distribution, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $-249.8M $1.8M $14.5M $17.1M $21.1M $107.5M $-36.1M $8.3M
Depreciation & Amortization $12.7M $12.3M $12.9M $12.1M $13.1M $14.2M $16.4M $17.3M
Depreciation — — — — — — — —
Amortization — — — — — — — —
Stock-Based Compensation $1.1M $3.7M $3.2M $5.8M $5.8M $9.3M $3.4M $3.5M
Net Cash from Operating Activities $10.6M $-3.9M $16.6M $27.5M $35.8M $389.0K $25.8M $31.4M
Investing Activities
Capital Expenditures $5.6M $13.7M $10.8M $9.9M $18.0K $13.6M $12.6M $8.6M
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-5.6M $-14.3M $-9.8M $-9.9M $8.8M $181.5M $-13.6M $-6.5M
Financing Activities
Dividends Paid $2.9M $2.9M $2.9M $3.0M $3.0M $3.0M $3.0M $3.0M
Stock Repurchases $0 $5.0M $10.0M $5.0M $0 $5.0M $0 $0
Net Cash from Financing Activities $-13.4M $-20.4M $-18.5M $-26.9M $9.3M $-166.3M $-43.6M $-28.8M
Net Change in Cash $-9.0M $-40.0M $-13.2M $-12.4M $60.4M $16.9M $-40.9M $3.5M
Free Cash Flow $5.0M $-17.6M $5.9M $17.6M $35.8M $-13.2M $13.2M $22.8M
← Newer Page 1 of 9 Older →